Bindumalini Raobaikady

Inhibition of MCF-7 breast cancer cell proliferation and in vivo steroid sulphatase activity by 2-methoxyoestradiol-bis-sulphamate

Bindumalini Raobaikady, Atul Purohit, Surinder K. Chander et al. · The Journal of Steroid Biochemistry and Molecular Biology · 2003 · 53 citations

Life Sciences, Biochemistry, Pharmacology +10

Inhibition of MDA-MB-231 cell cycle progression and cell proliferation by C-2-substituted oestradiolmono- andbis-3-O-sulphamates

Bindumalini Raobaikady, Michael Reed, Mathew P. Leese et al. · International Journal of Cancer · 2005 · 30 citations

Medicine, Oncology, Pharmacology +14

The therapeutic potential of a series of orally bioavailable anti-angiogenic microtubule disruptors as therapy for hormone-independent prostate and breast cancers

Stephen T. Newman, Paul Foster, Yu‐Kun Ho et al. · British Journal of Cancer · 2007 · 26 citations · Full text

Medicine, Oncology, Pharmacology +15

Treatment-related adverse events of antibody drug-conjugates in clinical trials

Harold Nathan Tan, Marta Ascanio Morcillo, Juanita Lopez et al. · Journal of Hematology & Oncology · 2025 · 25 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

The nature of inhibition of steroid sulphatase activity by tibolone and its metabolites

Bindumalini Raobaikady, Joanna M. Day, A. Purohit et al. · The Journal of Steroid Biochemistry and Molecular Biology · 2005 · 12 citations

Life Sciences, Biochemistry, Medicinal Chemistry +12